Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Best Evidence Interview: Use of Some SSRIs With Tamoxifen Increases Mortality in Breast Cancer Patie
Link ID 23695
Title Best Evidence Interview: Use of Some SSRIs With Tamoxifen Increases Mortality in Breast Cancer Patie
Url http://www.medscape.com/viewarticle/719116?src=rss
Description This best evidence interview with Catherine Kelly, MD, discusses a highly rated study on the potentially dangerous interaction between SSRIs and tamoxifen in cancer patients. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Mar 26, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. HPV16 Oral Cancer Link Tied to E6 and E7 Oncogenes
  Repressing E6 and E7 oncogene expression on the malignant phenotype of human papillomavirus (HPV)-16-positive oropharyngeal cancer cell lines induces apoptosis, researchers report in the March 18th issue of the Journal of the National Cancer Institute. Reuters Health Information
Category:   Articles > Hematology-Oncology


2. Jury Still Out on Genotyping Before Prescribing Tamoxifen
  Although a survey of British oncologists showed a mixed response to testing before prescribing tamoxifen, most agreed that drugs that might interact should be avoided. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Targeted Therapy in Biliary Tract Cancer: 2009 Update
  Biliary tract cancers (BTC) lack consensus regarding treatment strategy, but this review summarizes the new approaches for patients with BTC and the rationale for targeted therapies. Future Oncology
Category:   Articles > Hematology-Oncology


4. EGFR Possible Therapeutic Target in Triple-Negative Breast Cancer
  Although the study did not reach its primary endpoint, researchers say that EGFR should continue to be investigated as a potential therapeutic target. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. ESAs Increase Risk for Venous Thromboembolism But Do Not Reduce Blood Transfusions
  The new findings come from a study of erythropoiesis-stimulating agents used in cancer patients treated with chemotherapy in community practices. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS